These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 25531655)
1. The effect of metformin on cardiac fibrosis via differentiation of cardiac fibroblasts. Ünlü M; Balta Ş; Arslan Z; Öztürk C; Çelik T; Iyisoy A Cardiology; 2015; 130(1):52-3. PubMed ID: 25531655 [No Abstract] [Full Text] [Related]
2. Response to the paper by Ünlü et al. entitled 'The effect of metformin on cardiac fibrosis via differentiation of cardiac fibroblasts'. Li J; Song SJ Cardiology; 2015; 130(1):54. PubMed ID: 25531774 [No Abstract] [Full Text] [Related]
4. [The effect of metformin on myocardial tolerance to ischemia in rats with diabetes mellitus type 2]. Kravchuk EN; Grineva EN; Galagudza MM; Bairamov AA Patol Fiziol Eksp Ter; 2013; (4):32-4. PubMed ID: 24640771 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of metformin on myocardial injury in metabolic syndrome patients following percutaneous coronary intervention. Li J; Xu JP; Zhao XZ; Sun XJ; Xu ZW; Song SJ Cardiology; 2014; 127(2):133-9. PubMed ID: 24335026 [TBL] [Abstract][Full Text] [Related]
6. The cardioprotective effects of metformin. El Messaoudi S; Rongen GA; de Boer RA; Riksen NP Curr Opin Lipidol; 2011 Dec; 22(6):445-53. PubMed ID: 21897229 [TBL] [Abstract][Full Text] [Related]
7. Statin and myocardial ischemia-reperfusion injury. Hu J; Lu Y Int J Cardiol; 2016 Nov; 222():988. PubMed ID: 27526377 [No Abstract] [Full Text] [Related]
8. Cardiac conditioning: a review of evolving strategies to reduce ischaemia-reperfusion injury. Kharbanda RK Heart; 2010 Aug; 96(15):1179-86. PubMed ID: 20558460 [No Abstract] [Full Text] [Related]
10. Myocardial protection from ischemia-reperfusion injury post coronary revascularization. Binder A; Ali A; Chawla R; Aziz HA; Abbate A; Jovin IS Expert Rev Cardiovasc Ther; 2015; 13(9):1045-57. PubMed ID: 26202544 [TBL] [Abstract][Full Text] [Related]
11. [Trimetazidine, oxidative stress, and cell injury during myocardial reperfusion]. Ruiz-Meana M Rev Esp Cardiol; 2005 Aug; 58(8):895-7. PubMed ID: 16053822 [No Abstract] [Full Text] [Related]
12. Comparative analysis of early and delayed cardioprotective and antiarrhythmic efficacy of hypoxic preconditioning. Maslov LN; Lishmanov YB; Krylatov AV; Sementsov AS; Portnichenko AG; Podoksenov YK; Khaliulin IG Bull Exp Biol Med; 2014 Apr; 156(6):746-9. PubMed ID: 24824686 [TBL] [Abstract][Full Text] [Related]
13. Does growth differentiation factor 11 protect against myocardial ischaemia/reperfusion injury? A hypothesis. Yang Y; Yang Y; Wang X; Du J; Hou J; Feng J; Tian Y; He L; Li X; Pei H J Int Med Res; 2017 Dec; 45(6):1629-1635. PubMed ID: 27565745 [TBL] [Abstract][Full Text] [Related]
14. QiShenYiQi Pills® prevent cardiac ischemia-reperfusion injury via energy modulation. Lin SQ; Wei XH; Huang P; Liu YY; Zhao N; Li Q; Pan CS; Hu BH; Chang X; Fan JY; Yang XY; Wang CS; Liu HN; Han JY Int J Cardiol; 2013 Sep; 168(2):967-74. PubMed ID: 23168012 [TBL] [Abstract][Full Text] [Related]